Eton Pharmaceuticals Inc. (ETON)
14.09
0.67 (4.99%)
At close: Jan 15, 2025, 2:51 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -936.00K | -9.02M | -1.96M | -27.97M | -18.32M | -12.74M | -7.16M |
| Depreciation & Amortization | 901.00K | 1.77M | 462.00K | 651.00K | 447.00K | 63.00K | 13.00K |
| Stock-Based Compensation | 3.14M | 4.22M | 3.38M | 2.58M | 1.89M | 1.85M | 2.64M |
| Other Working Capital | 5.46M | 4.12M | -910.00K | -320.00K | -827.00K | -314.00K | 84.00K |
| Other Non-Cash Items | 117.00K | 127.00K | 148.00K | 1.39M | 16.00K | 2.58M | 1.29M |
| Deferred Income Tax | n/a | n/a | -546.00K | n/a | n/a | n/a | n/a |
| Change in Working Capital | 3.60M | 7.72M | -6.21M | 1.01M | -2.06M | 99.00K | 623.00K |
| Operating Cash Flow | 6.82M | 4.82M | -4.72M | -22.35M | -18.03M | -8.14M | -4.72M |
| Capital Expenditures | -775.00K | -2.79M | -3.26M | -50.00K | -1.85M | -236.00K | -130.00K |
| Acquisitions | n/a | n/a | 700.00K | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -2.75M | -2.55M | n/a | -750.00K | n/a | n/a |
| Investing Cash Flow | -775.00K | -2.79M | -2.56M | -50.00K | -1.85M | -236.00K | -130.00K |
| Debt Repayment | -1.16M | -385.00K | -150.00K | 2.48M | 4.75M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | -1.05M | n/a |
| Other Financial Acitivies | 198.00K | 251.00K | 541.00K | 367.00K | 453.00K | 205.00K | 18.00M |
| Financial Cash Flow | -957.00K | -134.00K | 391.00K | 31.63M | 5.20M | 21.96M | 18.00M |
| Net Cash Flow | 5.08M | 1.90M | -6.89M | 9.23M | -14.67M | 13.58M | 13.16M |
| Free Cash Flow | 6.04M | 2.03M | -7.98M | -22.40M | -19.87M | -8.38M | -4.85M |